FC Breedveld

8.0k total citations · 1 hit paper
102 papers, 6.2k citations indexed

About

FC Breedveld is a scholar working on Rheumatology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, FC Breedveld has authored 102 papers receiving a total of 6.2k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Rheumatology, 30 papers in Radiology, Nuclear Medicine and Imaging and 22 papers in Immunology. Recurrent topics in FC Breedveld's work include Rheumatoid Arthritis Research and Therapies (62 papers), Monoclonal and Polyclonal Antibodies Research (29 papers) and Systemic Lupus Erythematosus Research (27 papers). FC Breedveld is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (62 papers), Monoclonal and Polyclonal Antibodies Research (29 papers) and Systemic Lupus Erythematosus Research (27 papers). FC Breedveld collaborates with scholars based in Netherlands, United States and Germany. FC Breedveld's co-authors include Joachim R. Kalden, Josef S Smolen, Paul Emery, T. Huizinga, Peter Tugwell, Michael Schiff, P.L. van Riel, Gérard Eberl, K.W. Drossaers-Bakker and Aeilko H. Zwinderman and has published in prestigious journals such as The Lancet, The Journal of Immunology and Annals of the New York Academy of Sciences.

In The Last Decade

FC Breedveld

101 papers receiving 6.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A simplified disease activity index for rheumatoid arthritis for use in clinical practice

2003 795 citations Josef S Smolen, FC Breedveld et al. Lara D. Veeken profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
FC Breedveld Netherlands	40	4.1k	1.4k	1.3k	755	736	102	6.2k
Xavier Le Loët France	42	3.3k 0.8×	1.3k 0.9×	1.4k 1.0×	696 0.9×	685 0.9×	198	5.4k
M. H. van Rijswijk Netherlands	37	4.9k 1.2×	1.6k 1.1×	810 0.6×	1.1k 1.4×	648 0.9×	64	6.9k
Alain Cantagrel France	44	5.3k 1.3×	1.9k 1.3×	2.0k 1.6×	605 0.8×	859 1.2×	202	7.5k
Josef S Smolen Austria	19	4.2k 1.0×	1.6k 1.1×	1.6k 1.3×	1.2k 1.5×	585 0.8×	26	6.5k
E. Martín‐Mola Spain	44	4.2k 1.0×	1.5k 1.0×	1.6k 1.2×	409 0.5×	459 0.6×	113	6.0k
Thasia Woodworth United States	37	4.2k 1.0×	1.5k 1.0×	2.3k 1.8×	768 1.0×	602 0.8×	84	7.4k
Johannes C. Nossent Australia	44	4.5k 1.1×	924 0.6×	2.5k 2.0×	875 1.2×	888 1.2×	201	6.8k
Raimón Sanmartí Spain	40	3.6k 0.9×	1.3k 0.9×	1.6k 1.2×	771 1.0×	455 0.6×	263	5.3k
H. James Williams United States	27	5.2k 1.3×	2.1k 1.4×	1.2k 0.9×	342 0.5×	499 0.7×	80	6.9k
Mary Chester Wasko United States	33	3.4k 0.8×	1.2k 0.9×	976 0.8×	562 0.7×	315 0.4×	64	5.0k

Countries citing papers authored by FC Breedveld

Since Specialization

Citations

This map shows the geographic impact of FC Breedveld's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by FC Breedveld with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites FC Breedveld more than expected).

Fields of papers citing papers by FC Breedveld

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by FC Breedveld. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by FC Breedveld. The network helps show where FC Breedveld may publish in the future.

Co-authorship network of co-authors of FC Breedveld

This figure shows the co-authorship network connecting the top 25 collaborators of FC Breedveld. A scholar is included among the top collaborators of FC Breedveld based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with FC Breedveld. FC Breedveld is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Schoels, Monika, Daniel Aletaha, J. W. J. Bijlsma, et al.. (2010). Evidence for treating rheumatoid arthritis to target: results of a systematic literature search. Annals of the Rheumatic Diseases. 69(4). 638–643. 185 indexed citations

Genovese, Mark C., FC Breedveld, P. Emery, et al.. (2009). Safety of biological therapies following rituximab treatment in rheumatoid arthritis patients. Annals of the Rheumatic Diseases. 68(12). 1894–1897. 61 indexed citations

Kooij, S M van der, Jeska K de Vries‐Bouwstra, Y P M Goekoop-Ruiterman, et al.. (2007). Limited efficacy of conventional DMARDs after initial methotrexate failure in patients with recent onset rheumatoid arthritis treated according to the disease activity score. Annals of the Rheumatic Diseases. 66(10). 1356–1362. 71 indexed citations

Verpoort, K. N., Annette H M van der Helm–van Mil, Cornelia M. Jol‐van der Zijde, et al.. (2007). Association of smoking with the constitution of the anti–cyclic citrullinated peptide response in the absence of HLA–DRB1 shared epitope alleles. Arthritis & Rheumatism. 56(9). 2913–2918. 41 indexed citations

Smolen, Josef S, FC Breedveld, Michael Schiff, et al.. (2003). A simplified disease activity index for rheumatoid arthritis for use in clinical practice. Lara D. Veeken. 42(2). 244–257. 795 indexed citations breakdown →

Sont, Jacob K., et al.. (2002). High dose cyclophosphamide followed by autologous stem cell transplantation for the treatment of intractable rheumatoid arthritis (RA): a 2-year clinical and immunological follow-up. Arthritis Research. 4(Suppl 1). 103–103. 3 indexed citations

Goossens, Paulien H., G. J. Schouten, Bianca Heemskerk, et al.. (2001). The effect of promoter strength in adenoviral vectors in hyperplastic synovium.. PubMed. 18(5). 547–52. 6 indexed citations

Ronday, H. K., W.H. van der Laan, Paul P. Tak, et al.. (2001). Human granzyme B mediates cartilage proteoglycan degradation and is expressed at the invasive front of the synovium in rheumatoid arthritis. Lara D. Veeken. 40(1). 55–61. 73 indexed citations

Breedveld, FC. (2001). Is there a place for leflunomide in the treatment of rheumatoid arthritis?. The Lancet. 358(9289). 1198–1200. 9 indexed citations

10.

Laan, W.H. van der, et al.. (2000). Lack of effect of doxyxyxline on disease activity and pyridinoline excretion rates in rheumatoid arthritis : a double-blind placebo-controlled study: abstract. Annals of the Rheumatic Diseases. 59. 156. 1 indexed citations

11.

Drossaers-Bakker, K.W., et al.. (2000). A comparison of three radiologic scoring systems for the long-term assessment of rheumatoid arthritis: Findings of an ongoing prospective inception cohort study of 132 women followed up for a median of twelve years. Arthritis & Rheumatism. 43(7). 1465–1472. 21 indexed citations

12.

Drossaers-Bakker, K.W., et al.. (2000). Radiographic damage of large joints in long‐term rheumatoid arthritis and its relation to function. Lara D. Veeken. 39(9). 998–1003. 114 indexed citations

13.

Huizinga, T., V. Keijsers, G. Yanni, et al.. (2000). Are differences in interleukin 10 production associated with joint damage?. Lara D. Veeken. 39(11). 1180–1188. 79 indexed citations

14.

Huizinga, T., Eric L. Kaijzel, Eric Zanelli, et al.. (1999). Association of the TNF +489 polymorphism with susceptibility and radiographic damage in rheumatoid arthritis. Genes and Immunity. 1(2). 91–96. 58 indexed citations

15.

Horst‐Bruinsma, Irene E. van der, et al.. (1998). Influence of HLA-class II incompatibility between mother and fetus on the development and course of rheumatoid arthritis of the mother. Annals of the Rheumatic Diseases. 57(5). 286–290. 20 indexed citations

16.

Landewé, R. B. M., et al.. (1996). Low Dose Cyclosporine in Early Rheumatoid Arthritis: Effective and Safe after Two Years of Therapy when Compared with Chloroquine. Scandinavian Journal of Rheumatology. 25(5). 307–316. 8 indexed citations

17.

Wolde, S. ten, B. A. C. Dijkmans, J. J. van Rood, et al.. (1995). HUMAN LEUCOCYTE ANTIGEN PHENOTYPES AND GOLD-INDUCED REMISSIONS IN PATIENTS WITH RHEUMATOID ARTHRITIS. Lara D. Veeken. 34(4). 343–346. 2 indexed citations

18.

Ende, C.H.M. van den, et al.. (1995). DISCORDANCE BETWEEN OBJECTIVE AND SUBJECTIVE ASSESSMENT OF FUNCTIONAL ABLITY OF PATIENTS WITH RHEUMATOID ARTHRITIS. Lara D. Veeken. 34(10). 951–955. 36 indexed citations

19.

Otten, Henny G., et al.. (1992). IgA rheumatoid factor in mucosal fluids and serum of patients with rheumatoid arthritis: immunological aspects and clinical significance. Clinical & Experimental Immunology. 90(2). 256–259. 10 indexed citations

20.

Breedveld, FC, Willem E. Fibbe, & A. Cats. (1988). NEUTROPENIA AND INFECTIONS IN FELTY'S SYNDROME. Lara D. Veeken. 27(3). 191–197. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact